UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Buckhead Capital Management LLC

Buckhead Capital Management LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,296 shares of the healthcare conglomerate’s stock after selling 132 shares during the quarter. UnitedHealth Group accounts for approximately 2.3% of Buckhead Capital Management LLC’s holdings, making the stock its 7th biggest position. Buckhead Capital Management LLC’s holdings in UnitedHealth Group were worth $7,232,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. International Assets Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Accredited Investors Inc. grew its holdings in shares of UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after acquiring an additional 776,516 shares in the last quarter. Raymond James & Associates raised its holdings in shares of UnitedHealth Group by 33.1% during the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after acquiring an additional 587,088 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec grew its stake in UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares in the last quarter. Finally, State Street Corp raised its stake in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, KeyCorp reissued an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 0.7 %

Shares of UNH stock opened at $531.31 on Friday. The stock has a market cap of $488.95 billion, a price-to-earnings ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61. The firm has a fifty day moving average of $524.58 and a 200-day moving average of $563.71. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company posted $5.83 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.